Search for: "Eli Lilly "
Results 1621 - 1640
of 2,131
Sorted by Relevance
|
Sort by Date
7 Mar 2016, 1:55 am
. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive explanation of trademarks | Actavis v Lilly.Never… [read post]
25 Jun 2018, 7:15 am
When Sky v SkyKick leaves rightsholders in limbo | The Intellectual Property Owners Association | Report on IPO’s 2018 European Practice Committee Conference (1/2) | Book review: Propertizing European Copyright – History, Challenges and Opportunities | GDPR notification | Thursday Thingies | Around the IP Blogs.Never Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial… [read post]
17 Jan 2019, 11:09 pm
In many circumstances, she had to make a decision because the law required it but it was not necessarily the best thing for the family.Inevitably there was some discussion about the implications of Actavis v Eli Lilly [2017] UKSC 48. [read post]
22 Jun 2018, 3:18 am
When Sky v SkyKick leaves rightsholders in limbo | The Intellectual Property Owners Association | Report on IPO’s 2018 European Practice Committee Conference (1/2) | Book review: Propertizing European Copyright – History, Challenges and Opportunities | GDPR notification | Thursday Thingies | Around the IP Blogs.Never Too Late 194 [weeks ending 13th and 20th May] Important amendments under Mexican law regarding patents, utility models and industrial designs… [read post]
27 Aug 2013, 7:23 am
Four companies (GlaxoSmithKline, Pfizer, Eli Lilly, and Schering-Plough) accounted for more than half (53 percent or $10.5 billion) of all financial penalties imposed over the past two decades. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on the gene patent controversy… [read post]
11 Feb 2010, 4:37 am
Here are a few samples we found so far - the first four have been truly filed under the new rules; the last three have not but have some attributes that address some of the new requirements: - Fortune Brands (preliminary proxy filed under new rules) - Eli Lilly (preliminary proxy filed under new rules) - Analog Devices (filed early under new rules) - Hovanian Enterprises (another early adopter) - Point Blank Solutions (director qualification language from proxy contest two… [read post]
8 Mar 2016, 6:02 am
, Day 24: Missing Balance on IP Border Measures, Day 25: The Treaties With the Treaty, Day 26: Why It Limits Canadian Cultural Policies, Day 27: Source Code Disclosure Confusion, Day 28: Privacy Risks from Source Code Rules, Day 29: Cultural Policy Innovation Uncertainty, Day 30: Losing Our Way on Geographical Indications, Day 31: Canadian Trademark Law Overhaul, Day 32: Illusory Safeguards Against Encryption Backdoors, Day 33: Setting the Rules for a Future Pharmacare Program, Day 34: PMO Was… [read post]
27 Jan 2024, 9:13 am
Eli Lilly & Co., 701 So. 2d 344, 347 (Fla. 1997) (The “statute of limitations for DES negligence actions begins to run on the date the plaintiff knew or should have known of his or her injury”); Fla. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
29 Apr 2015, 6:35 am
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
2 Apr 2008, 5:55 am
Eli Lilly, No. 5:04-CV-1477,2006 WL 2038436 (N.D.N.Y. [read post]
22 Mar 2017, 3:02 pm
I’ve written a lot about these issues in recent weeks: how foreign funding has actually surpassed funding from Canadian broadcasters and distributors for English language TV production why tax schemes for online advertising to support Canadian media won’t work why copyright reform is not the answer for Canadian media how Canadian copyright law is now one of the world’s toughest on piracy why fair dealing in Canada and the shift to digital has been a success story how Canada’s… [read post]
18 Sep 2007, 5:29 am
Eli Lilly and Co. , 488 F.3d 1026 (D.C.Cir. [read post]
18 Nov 2017, 9:00 pm
He is a past director of global corporate affairs for Elanco, a subsidiary of Eli Lilly and Company. [read post]
4 May 2011, 8:32 am
To counter these arguments, proponents of the whistleblower program cite to other successful programs with robust monetary rewards like that under the False Claims Act, which helped facilitate large settlements with pharmaceutical giants Pfizer and Eli Lilly for corporate misconduct. [read post]
3 Jul 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
25 Oct 2009, 10:18 am
Hasbro, Blackrock, Pfizer, Wells Fargo, Eli Lilly, Morgan Stanley, Deutsche Bank, Gannett, Merck, UPS, McDonald's, Microsoft, American Express, and Amazon, among others. [read post]
9 Sep 2024, 10:39 am
Parvin was recently appointed to co-lead counsel in the Glucagon-like Peptide-1 (GLP-1) Receptor Agonists Litigation, where patients are filing lawsuits against pharmaceutical companies Novo Nordisk and Eli Lilly. [read post]
23 Sep 2024, 8:02 am
In 2014, the same Court had itself revoked certain claims relating to particular dosages for administering raloxifene, on the grounds that they were excluded from patentability (Paris Court of Appeal, 12 March 2014, Eli Lilly and company et al. v. [read post]
